Leadership & perspective
Chief Executive Officer · Japan
2026-09-23 edition
A medicine supply plan is credible only when its quality decisions can withstand the pressure to ship.
Section · The leadership journal
A pharmaceutical CEO cannot protect a quality decision merely by promising not to interfere. Capacity, executive attention and the treatment of commercial consequences determine whether that promise works in practice.
Read the essayResilience programmes often count sources at the point of approval. The harder executive question is whether those options remain technically, commercially and operationally available when the original supply route is interrupted.
Read the essayA low-volume presentation can impose work that ordinary product-margin reports barely show. Portfolio decisions need a record of that work and of the customer obligations that make some apparently inefficient products worth retaining.
Read the essay